Table 1 Inclusion and exclusion criteria

For the person with aMCI:

1. Written informed consent for participation.

2. A formal diagnosis of amnestic mild cognitive impairment [1] (single domain or multidomain) in the last 6 months (by neuropsychological evaluation)

OR

A CDR score of 0 or 0.5 and a TICS-M score of at least 25 on the TICS-M.

3. Aged at least 50 years.

4. Either not taking or stable on nootropic(s) and/or pain medication on a dose and frequency that affects cognitive abilities for at least 3 months.

5. Fluent in English.

For the study partner:

6. Written informed consent for participation.

7. Aged at least 21 years.

8. A score of at least 32 on the TICS-M

9. Study partner has at least twice-weekly contact with the participant.

For the person with aMCI:

1. MRI contraindications (e.g. ferrous metal in the body, claustrophobia, pregnancy)

For both the person with aMCI patient and study partner:

2. Physical impairments, language comprehension deficits, or significant hearing disturbances that would limit ability to perform tasks or participate in the intervention